The latest price target for Artivion (NYSE:AORT) was reported by JMP Securities on December 10, 2024. The analyst firm set a price target for $33.00 expecting AORT to rise to within 12 months (a possible 15.87% upside). 15 analyst firms have reported ratings in the last year.

The latest analyst rating for Artivion (NYSE:AORT) was provided by JMP Securities, and Artivion reiterated their market outperform rating.

There is no last upgrade for Artivion

There is no last downgrade for Artivion.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Artivion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Artivion was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.

While ratings are subjective and will change, the latest Artivion (AORT) rating was a reiterated with a price target of $33.00 to $33.00. The current price Artivion (AORT) is trading at is $28.48, which is out of the analyst’s predicted range.